- ►diabetesjournals.org L Weekers, B Bouhanick, S Hadjadj, Y Gallois, R … - Diabetes, 2005 - Am Diabetes Assoc ACE inhibition protects kidney function, but ACE insertion/deletion (I/D) polymorphism affects
renal prognosis in type 1 diabetic patients. ACE genotype may influence the renal benefits of
ACE inhibition. We studied the impact of ACE I/D polymorphism on the renal ... Cited by 9 - Related articles - BL Direct - All 5 versions
HCPHY Choi, BSKSW Kang, KHCSK Ha, … - Kidney Blood Press …, 2006 - content.karger.com Page 1. Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com Original Paper Kidney
Blood Press Res 2006;29:216–224 DOI: 10.1159/000095736 Antiproteinuric Effect of Losartan
in Non-Diabetic Renal Disease Is Not Dependent on ACE Insertion/ ... Cited by 4 - Related articles - BL Direct - All 5 versions
- ►rug.nl [PDF] PT Luik, K Hoogenberg, MN Kerstens, BJ Beusekamp, … - Diabetologia, 2003 - Springer Aim/hypothesis. The renin-angiotensin-aldosterone system is important in diabetic
nephropathy, with the angiotensin-converting-enzyme DD-genotype being a renal risk
factor. The D-allele is associated with high- er ACE concentrations, but functional ... Cited by 14 - Related articles - BL Direct - All 9 versions
[CITATION] van GH, Navis G. Individual differences in renal ACE activity in healthy rats predict …
- ►ahajournals.org M Marre, B Bouhanick, G Berrut, Y Gallois, JJ Le Jeune … - Hypertension, 1999 - Am Heart Assoc Abstract—Hyperglycemia causes capillary vasodilation and high glomerular capillary hydraulic
pressure, which lead to glomerulosclerosis and hypertension in type 1 diabetic subjects. The
insertion/deletion (I/D) polymorphism of the angiotensin I–converting enzyme (ACE) gene ... Cited by 19 - Related articles - BL Direct - All 5 versions
PH Winocour, C Catalano, TH Thomas, R … - DIABETIC …, 1993 - interscience.wiley.com The relationship between erythrocyte sodium lithium countertransport activity (SLC), total exchangeable
sodium (NaE), and hormonal control of renal function was examined in 40 normotensive,
normoalbuminuric, non-neuropathic Type 1 diabetic subjects, of whom 8 had elevated ... Cited by 3 - Related articles - BL Direct - All 3 versions
E Coto, R Marin, V Alvarez, M Praga, C Fernandez … - Nefrologia, 2005 - revistanefrologia.com E. Coto*, R. Marín*, V. Álvarez*, M. Praga**, C. Fernández Andrade***, M. Arias****, R.
Poveda*****, M. Vallés******, JM Galcerán*******, J. Luño********, F. Rivera********* and JM
Campistol********** *Molecular Genetics. Hospital Central de Asturias and Instituto Reina ... Cited by 4 - Related articles - View as HTML - All 3 versions
- ►nih.gov HH Parving, D de Zeeuw, ME Cooper, G Remuzzi, N … - J Am Soc …, 2008 - Am Soc Nephrol ABSTRACT Losartan treatment reduced renal outcomes in proteinuric patients with type 2 diabetes
in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan
(RENAAL) study. It is unknown whether an insertion (I)/deletion (D) polymorphism in the ... Cited by 13 - Related articles - All 6 versions
S Björck, M Aurell, LE Bresäter, H Herlitz, L … - Scandinavian journal of …, 1990 - ncbi.nlm.nih.gov The role of the renin angiotensin system for the regulation of kidney function in diabetes mellitus
is uncertain. Results from studies in diabetic animals suggest that a reduced activity in this system
contributes to the renal hyperperfusion and hyperfiltration in diabetes. The renal ... Cited by 6 - Related articles - All 2 versions
PT Luik, MN Kerstens, K Hoogenberg, GJ … - The ACE (I/D) …, 2003 - dissertations.ub.rug.nl Page 43. Chapter 2 Low plasma aldosterone despite normal plasma renin activity in
uncomplicated type 1 diabetes mellitus: effects of RAAS-stimulation. PT Luik1, MN
Kerstens2, K Hoogenberg3, GJ Navis1, RPF Dullaart2. Department ... Cited by 7 - Related articles - View as HTML - BL Direct - All 9 versions
